Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1 Phenyl 1 Diethylaminocarbonyl 2 Aminomethylcyclopropane Hcl
2. 1-phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane Hcl
3. F 2207
4. F-2207
5. F2207
6. Ixel
7. Midalcipran
8. Milnacipran Hydrochloride
9. Savella
1. 92623-85-3
2. Dextromilnacipran
3. Levomilnacipran
4. 96847-55-1
5. Milnacipranum [latin]
6. Toledomin
7. Milnacipran [inn]
8. Ixel
9. (1r,2s)-2-(aminomethyl)-n,n-diethyl-1-phenylcyclopropane-1-carboxamide
10. Es1o38j3c4
11. G56vk1hf36
12. F2696
13. Milnacipran (inn)
14. (+-)-milnacipran
15. (1r,2s)-2-(aminomethyl)-n,n-diethyl-1-phenylcyclopropanecarboxamide
16. Impulsor
17. F2207
18. Milnacipranum
19. Milnace
20. (1r,2s)-2-(aminomethyl)-n,n-diethyl-1-phenyl-cyclopropane-1-carboxamide
21. Cyclopropanecarboxamide, 2-(aminomethyl)-n,n-diethyl-1-phenyl-,(1r,2s)-rel-
22. (-)-milnacipran
23. Milnacipran [inn:ban]
24. Unii-es1o38j3c4
25. Unii-g56vk1hf36
26. (?)-milnacipran
27. Milnacipran [mi]
28. Cyclopropanecarboxamide, 2-(aminomethyl)-n,n-diethyl-1-phenyl-, Cis-(+-)-
29. Milnacipran [vandf]
30. Schembl8099
31. Milnacipran [who-dd]
32. (1r,2s)-milnacipran
33. Milnacipran [ema Epar]
34. Chembl252923
35. Dtxsid3048287
36. Bdbm86420
37. Chebi:94468
38. Zinc14037
39. Dtxsid601025164
40. Hy-b0168
41. (+-)-cis-2-(aminomethyl)-n,n-diethyl-1-phenylcyclopropanecarboxamide
42. Ncgc00165825-01
43. Hy-14794
44. Milnacipran Pierre Fabre Medicament
45. Cas_92623-85-3
46. Cs-0003566
47. C16729
48. D08222
49. F-2696
50. Ab00640027_06
51. 623m853
52. Q421058
53. (1rs,2sr)-2-(aminomethyl)-n,n-diethyl-1-phenylcyclopropanecarboxamide
54. Cyclopropanecarboxamide, 2-(aminomethyl)-n,n-diethyl-1-phenyl-, (1r,2s)-
55. Cyclopropanecarboxamide, 2-(aminomethyl)-n,n-diethyl-1-phenyl-, (1r,2s)-rel-
56. Cyclopropanecarboxamide, 2-(aminomethyl)-n,n-diethyl-1-phenyl-, (1r-cis)-
57. F0f
| Molecular Weight | 246.35 g/mol |
|---|---|
| Molecular Formula | C15H22N2O |
| XLogP3 | 1.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 5 |
| Exact Mass | 246.173213330 g/mol |
| Monoisotopic Mass | 246.173213330 g/mol |
| Topological Polar Surface Area | 46.3 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 295 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 2 | |
|---|---|
| Drug Name | Savella |
| PubMed Health | Milnacipran (By mouth) |
| Drug Classes | Central Nervous System Agent |
| Drug Label | Milnacipran hydrochloride is a selective norepinephrine and serotonin reuptake inhibitor; it inhibits norepinephrine uptake with greater potency than serotonin. It is a racemic mixture with the chemical name: ()-[1R(S),2S(R)]-2-(aminomethyl)-N,N-di... |
| Active Ingredient | Milnacipran hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 25mg; 100mg; 50mg; 12.5mg |
| Market Status | Prescription |
| Company | Cypress Bioscience |
| 2 of 2 | |
|---|---|
| Drug Name | Savella |
| PubMed Health | Milnacipran (By mouth) |
| Drug Classes | Central Nervous System Agent |
| Drug Label | Milnacipran hydrochloride is a selective norepinephrine and serotonin reuptake inhibitor; it inhibits norepinephrine uptake with greater potency than serotonin. It is a racemic mixture with the chemical name: ()-[1R(S),2S(R)]-2-(aminomethyl)-N,N-di... |
| Active Ingredient | Milnacipran hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 25mg; 100mg; 50mg; 12.5mg |
| Market Status | Prescription |
| Company | Cypress Bioscience |
Treatment of stroke
Analgesics, Non-Narcotic
A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)
Serotonin and Noradrenaline Reuptake Inhibitors
Drugs that selectively block or suppress the plasma membrane transport of SEROTONIN and NORADRENALINE into axon terminals and are used as ANTIDEPRESSIVE AGENTS. (See all compounds classified as Serotonin and Noradrenaline Reuptake Inhibitors.)
N06AX17
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
N - Nervous system
N06 - Psychoanaleptics
N06A - Antidepressants
N06AX - Other antidepressants
N06AX17 - Milnacipran
N - Nervous system
N06 - Psychoanaleptics
N06A - Antidepressants
N06AX - Other antidepressants
N06AX28 - Levomilnacipran
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
REF. STANDARDS & IMPURITIES
USP
ANALYTICAL
ABOUT THIS PAGE
A Milnacipran manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Milnacipran, including repackagers and relabelers. The FDA regulates Milnacipran manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Milnacipran API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Milnacipran manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Milnacipran supplier is an individual or a company that provides Milnacipran active pharmaceutical ingredient (API) or Milnacipran finished formulations upon request. The Milnacipran suppliers may include Milnacipran API manufacturers, exporters, distributors and traders.
click here to find a list of Milnacipran suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Milnacipran Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Milnacipran GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Milnacipran GMP manufacturer or Milnacipran GMP API supplier for your needs.
A Milnacipran CoA (Certificate of Analysis) is a formal document that attests to Milnacipran's compliance with Milnacipran specifications and serves as a tool for batch-level quality control.
Milnacipran CoA mostly includes findings from lab analyses of a specific batch. For each Milnacipran CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Milnacipran may be tested according to a variety of international standards, such as European Pharmacopoeia (Milnacipran EP), Milnacipran JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Milnacipran USP).
LOOKING FOR A SUPPLIER?
